Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZERVIATE ®safely and effectively. See full prescribing information for ZERVIATE ®. ZERVIATE ®(cetirizine ophthalmic solution) 0.24%, for topical ophthalmic use Initial U.S. Approval: 1995
Medication labelWhy this: Advisory · dailymed-prescription
ZERVIATE ® (cetirizine ophthalmic solution) 0.24% is indicated for the treatment of ocular itching associated with allergic conjunctivitis.
- generic_name
- cetirizine
- product_names
- cetirizine
- ndc
- 82667-015, 82667-015-24
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en